Calamos Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Calamos Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$98.98 - $115.74 $12.7 Million - $14.9 Million	-128,495 Reduced 56.24%	100,000 $11.6 Million
Q1 2023 May 03, 2023	BUY	$107.32 - $113.5 $18.5 Million - $19.5 Million	171,937 Added 304.0%	228,495 $24.9 Million
Q4 2022 Jan 25, 2023	BUY	$62.39 - $113.8 $3.53 Million - $6.44 Million	56,558 New	56,558 $0
Q1 2022 May 03, 2022	SELL	$86.42 - $109.81 $4.89 Million - $6.21 Million	-56,567 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$98.56 - $119.91 $2.25 Million - $2.74 Million	-22,849 Reduced 28.77%	56,567 $6.1 Million

Q3 2021 Oct 26, 2021	BUY	$91.91 - $110.37 $2.37 Million - $2.84 Million	25,738 Added 47.95%	79,416 $8.7 Million
Q2 2021 Jul 22, 2021	BUY	$86.24 - $95.92 $2.98 Million - $3.32 Million	34,564 Added 180.83%	53,678 $5.03 Million
Q1 2021 Apr 12, 2021	SELL	$71.83 - $95.48 $51,142 - $67,981	-712 Reduced 3.59%	19,114 $1.76 Million
Q4 2020 Jan 27, 2021	BUY	$67.0 - $84.39 $139,025 - $175,109	2,075 Added 11.69%	19,826 $1.45 Million
Q3 2020 Oct 26, 2020	BUY	$55.23 - $79.93 $333,478 - $482,617	6,038 Added 51.55%	17,751 $1.38 Million
Q2 2020 Jul 27, 2020	BUY	$30.2 - $56.98 $353,732 - $667,406	11,713 New	11,713 $651,000
Q1 2020 Apr 28, 2020	SELL	$24.87 - $38.56 $333,258 - $516,704	-13,400 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$22.81 - $28.48 $305,654 - $381,632	13,400 New	13,400 $322,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.